Canaccord Notes HealthStream, Inc. (HSTM) Well-Positioned Amid Rising AI Pressures on Software Firms

By Laiba Immad | March 02, 2026, 10:23 AM

HealthStream, Inc. (NASDAQ:HSTM) is among the 12 Most Promising Small-Cap Stocks According to Wall Street Analysts.

Canaccord Notes HealthStream, Inc. (HSTM) Well-Positioned Amid Rising AI Pressures on Software Firms

HealthStream, Inc. (NASDAQ:HSTM) is next on our list of most promising stocks.

TheFly reported on February 25 that Canaccord reduced its price target for HSTM from $25 to $21 and maintained a Hold rating. According to the firm, despite mounting investor fears about AI impacting SaaS firms, the company's fourth-quarter 2025 performance was excellent. Management discussed these issues and made the case that HSTM is in a better position than many other software businesses to handle the pressures posed by AI during the results call.

On February 23, HealthStream, Inc. (NASDAQ:HSTM) announced its results for the fourth quarter and the entire year 2025. According to the company, its Q4 revenue hit a record $79.7 million, up 7.4% over the previous year. According to the report, operational income and net income, which came to $2.4 million and $2.5 million, respectively, were impacted by a $3.8 million stock-based compensation charge associated with a CEO share contribution. Non-GAAP operating income surged 31.7% to $6.2 million, and non-GAAP EPS rose to $0.18 once this effect was eliminated. Adjusted EBITDA rose by 16.4% to $18.8 million.

In addition, for the full year, the corporation reported that its revenue reached $304.1 million, which is up 4.3%, while adjusted EBITDA grew 7.5% to $71.8 million. The company also completed two acquisitions, repurchased $10 million in shares, and increased its quarterly dividend to $0.035 per share.

HealthStream, Inc. (NASDAQ:HSTM) is a healthcare workforce solutions company providing training, credentialing, and compliance software for hospitals and healthcare organizations. Its cloud-based platforms help improve staff competency, regulatory adherence, and overall patient care quality.

While we acknowledge the potential of HSTM as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you’re looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock.

READ NEXT: 14 Best GARP Stocks to Buy According to Analysts and 14 Best Affordable Dividend Stocks to Buy According to Analysts.

Disclosure: None. Follow Insider Monkey on Google News.

Mentioned In This Article

Latest News